Medicare Enrolled

Dr. Francisco Pardo, M.D.

Family Medicine · San Diego, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1855 1ST AVE, San Diego, CA 92101
6197937988
In practice since 2006 (19 years)
NPI: 1699844621 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pardo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pardo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pardo

Dr. Francisco Pardo is a family medicine specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pardo performed 2,067 Medicare services across 382 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pardo received a total of $6,682 from 37 pharmaceutical and/or device companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pardo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 10% volume in CA $6,682 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,067
Medicare services
Top 10% in CA for family medicine
382
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
1,199 $1 $40
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
227 $151 $304
Opioid use disorder treatment, subsequent month, 60+ minutes
Office-based treatment for opioid use disorder involving care coordination, individual therapy, group therapy, and counseling. This code applies to subsequent calendar months with a session lasting at least 60 minutes.
83 $294 $500
Complete ultrasound scan of joint
An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures.
77 $46 $259
Tendon injection at attachment site
A procedure involving the injection of medication into a tendon where it attaches to bone or muscle.
76 $49 $129
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
74 $226 $341
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
59 $48 $89
Office-based opioid use disorder treatment, initial month (70+ min)
This service covers comprehensive office-based treatment for opioid use disorder during the first calendar month, requiring at least 70 minutes of time. It includes developing a treatment plan, care coordination, and individual or group therapy and counseling.
38 $321 $500
Psychotherapy and evaluation, 1 hour
A combined session involving psychotherapy and an evaluation and management visit lasting one hour.
34 $96 $227
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
33 $108 $227
Home visit, established patient, high complexity
A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes.
27 $154 $370
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
22 $78 $192
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
22 $108 $200
High-intensity behavioral counseling for STI prevention, 30 minutes
A 30-minute face-to-face session providing education, skills training, and guidance to help change sexual behavior and prevent sexually transmitted infections.
19 $28 $57
Annual alcohol misuse screening, 5 to 15 minutes 18 $20 $39
Annual depression screening 17 $20 $39
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
16 $138 $246
Annual intensive behavioral therapy for cardiovascular disease, 15 minutes
A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually.
14 $27 $54
Smoking cessation counseling, more than 10 minutes
Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes.
12 $29 $59
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,682
Total received (2018-2024)
Avg $955/year across 7 years
Top 6% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
323
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,682 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$306
2023
$936
2022
$1,137
2021
$1,161
2020
$1,089
2019
$921
2018
$1,131

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$172
ViiV Healthcare Company
$78
Gilead Sciences, Inc.
$34
Novartis Pharmaceuticals Corporation
$22
Top 3 companies account for 92.8% of 2024 payments
All-time payments by company (2018-2024) ›
ViiV Healthcare Company
$1,099
Gilead Sciences, Inc.
$1,033
GlaxoSmithKline, LLC.
$934
EMD Serono, Inc.
$715
Merck Sharp & Dohme Corporation
$377
Kowa Pharmaceuticals America, Inc.
$364
Lilly USA, LLC
$364
Janssen Products, LP
$237
ABBVIE INC.
$181
Avanir Pharmaceuticals, Inc.
$167
Janssen Biotech, Inc.
$140
Aytu BioScience, Inc
$138
Amarin Pharma Inc.
$120
Eisai Inc.
$93
Antares Pharma, Inc.
$90
AbbVie Inc.
$66
Theratechnologies Inc.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$56
Amgen Inc.
$50
Novo Nordisk Inc
$44
Arbor Pharmaceuticals, Inc.
$37
Kaleo, Inc.
$36
PFIZER INC.
$34
Dynavax Technologies Corporation
$31
Johnson & Johnson Surgical Vision, Inc.
$23
Novartis Pharmaceuticals Corporation
$22
AbbVie, Inc.
$21
Seqirus USA Inc
$21
Biohaven Pharmaceuticals, Inc.
$17
Supernus Pharmaceuticals, Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
Ultragenyx Pharmaceutical Inc.
$14
INSYS Therapeutics Inc
$13
Shire North American Group Inc
$13
Purdue Pharma L.P.
$13
Azurity Pharmaceuticals, Inc.
$13
Galderma Laboratories, L.P.
$12
Top 3 companies account for 45.9% of all-time payments
Associated products mentioned in payments ›
ANORO ELLIPTA · AREXVY · BAQSIMI · BELSOMRA · CABENUVA · CREON · CRYSVITA · DOVATO · Dayvigo · Descovy · EGRIFTA · ELIQUIS · EMGALITY · Edarbi · Evzio · FARXIGA · FLUCELVAX QUADRIVALENT · HUMALOG · Heplisav-B · Horizant · ISENTRESS · JANUVIA · LEQVIO · Livalo · MYDAYIS · NUEDEXTA · NURTEC ODT · Natesto · OTREXUP · Ozempic · PREVNAR - 13 · PREZCOBIX · QULIPTA · RUKOBIA · Repatha · SEROSTIM · SHINGRIX · SIVEXTRO · SYMPROIC · SYMTUZA · SYNDROS · Serostim · Symtuza · TLANDO · TRELEGY ELLIPTA · TRINTELLIX · TROGARZO · TRULICITY · Trintellix · UBRELVY · VRAYLAR · Vascepa · XYOSTED · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for family medicine in CA.

Looking for a family medicine specialist in San Diego?
Compare family medicine physicians in the San Diego area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
1,207
Per 100K population
36.8
County median income
$102,285
Nearest hospital
NMC San Diego
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pardo is a clinical cardiology specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement in the top 6% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pardo experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Pardo performed 1,199 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pardo receive payments from pharmaceutical companies?
Yes. Dr. Pardo received a total of $6,682 from 37 companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pardo's costs compare to other family medicine physicians in San Diego?
Dr. Pardo's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pardo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →